Analysed GUARDANT HEALTH INC (GH:NASDAQ) News Sources
Immuno-Oncology Diagnostics Market to Reach $11.1B by 2030 as Checkpoint Inhibitor and Cell Therapy Pipelines Drive Demand for Companion Tests
16-10-2026
yahoo.com
FDA Advisors Said It Should Approve the Grail Multicancer Blood Test. The Stock Rises Sharply.
24-09-2026
yahoo.com
Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Melanoma
05-10-2026
yahoo.com
Liquid Biopsy Market to Reach US$15.1 Billion by 2030 at 13.2% CAGR, Driven by Early Cancer Detection and Precision Medicine
08-10-2026
yahoo.com
Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026
08-10-2026
yahoo.com
Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer
08-10-2026
yahoo.com
Liquid Biopsy Market Research to Reach USD 27.42 Billion by 2035 as Cancer Blood Tests, AI Diagnostics and Precision Oncology Advance
14-10-2026
yahoo.com
Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests
15-10-2026
yahoo.com
What is the current price of GUARDANT HEALTH INC (GH:NASDAQ)?
The current price of GUARDANT HEALTH INC (GH:NASDAQ) is $158.16.
GUARDANT HEALTH INC (GH:NASDAQ) absolute price change since previous trading day?
The absolute price change of GUARDANT HEALTH INC (GH:NASDAQ) since the previous trading day is $-7.72.
GUARDANT HEALTH INC (GH:NASDAQ) percentage price change since previous trading day?
The percentage price change of GUARDANT HEALTH INC (GH:NASDAQ) since the previous trading day is -4.654%.
What is the most recent average sentiment score for GUARDANT HEALTH INC (GH:NASDAQ)?
The most recent average sentiment score for GUARDANT HEALTH INC (GH:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for GUARDANT HEALTH INC (GH:NASDAQ)?
The most recent sentiment for GUARDANT HEALTH INC (GH:NASDAQ) is .
SEC-8K** Filing Available For GUARDANT HEALTH INC (GH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.